Page last updated: 2024-08-24

lerisetron and Neoplasms

lerisetron has been researched along with Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calvo, R; Gonzalo, A; Jiménez, RM; Lucero, ML; Orjales, A; Raczka, E; Suárez, E; Trocóniz, IF	1

Other Studies

1 other study(ies) available for lerisetron and Neoplasms

Article	Year
Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer. Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:5 Topics: Adult; Antiemetics; Benzimidazoles; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Neoplasms; Orosomucoid; Piperidines; Protein Binding; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serum Albumin	1998

Article

Year

Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.

Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:5

Topics: Adult; Antiemetics; Benzimidazoles; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Neoplasms; Orosomucoid; Piperidines; Protein Binding; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serum Albumin

1998